Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Yarnoff

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Medical Economics|March 21, 2023
Public health impact and economic value of booster vaccination with Pfizer-BioNTech COVID-19 vaccine, bivalent (Original and Omicron BA.4/BA.5) in the United StatesManuela Di Fusco, Kinga Marczell, Elizabeth Thoburn, et al.
Expert Review of Vaccines|June 23, 2026
Cost-effectiveness and public health impact of RSV immunization for all infants in Japan: a mixed strategy with nirsevimab and RSVpreFNaruhiko Ishiwada, Xinyu Wang, Takeshi Arashiro, et al.
Public Health Nutrition|October 25, 2021
Estimating the cost-effectiveness of the Sodium Reduction in Communities ProgramBenjamin Yarnoff, Emily Teachout, Kara MacLeod, et al.
Vaccine|January 15, 2019
Provider time and costs to vaccinate adult patients: Impact of time counseling without vaccinationAngela Shen, Olga Khavjou, Grant King, et al.
Expert Review of Vaccines|May 13, 2025
Modeling the potential public health and economic impact and cost-effectiveness of vaccination strategies using an adapted COVID-19 vaccine in MexicoCarlos Fernando Mendoza, Jose Luis Huerta, Iustina Chirila, et al.
Medical Care|April 26, 2019
Estimating the Costs and Income of Providing Vaccination to Adults and ChildrenBenjamin Yarnoff, David Kim, Fangjun Zhou, et al.
Vaccine|September 10, 2019
Analysis of the profitability of adult vaccination in 13 private provider practices in the United StatesBenjamin Yarnoff, Olga Khavjou, Grant King, et al.
Maternal and Child Health Journal|December 15, 2018
Standardized Cost Estimates for Home Visiting: Pilot Study of the Home Visiting Budget Assistance Tool (HV-BAT)Benjamin Yarnoff, Olga Khavjou, Christina Bradley, et al.
Human Vaccines & Immunotherapeutics|September 29, 2023
Cost-effectiveness analysis of PCV20 to prevent pneumococcal disease in the Canadian pediatric populationDerek Lytle, Ana Gabriela Grajales Beltrán, Johnna Perdrizet, et al.
Preventing Chronic Disease|November 7, 2014
Using simulation to compare established and emerging interventions to reduce cardiovascular disease risk in the United StatesJack Homer, Kristina Wile, Benjamin Yarnoff, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Medical Economics|March 21, 2023
Public health impact and economic value of booster vaccination with Pfizer-BioNTech COVID-19 vaccine, bivalent (Original and Omicron BA.4/BA.5) in the United StatesManuela Di Fusco, Kinga Marczell, Elizabeth Thoburn, et al.
Expert Review of Vaccines|June 23, 2026
Cost-effectiveness and public health impact of RSV immunization for all infants in Japan: a mixed strategy with nirsevimab and RSVpreFNaruhiko Ishiwada, Xinyu Wang, Takeshi Arashiro, et al.
Public Health Nutrition|October 25, 2021
Estimating the cost-effectiveness of the Sodium Reduction in Communities ProgramBenjamin Yarnoff, Emily Teachout, Kara MacLeod, et al.
Vaccine|January 15, 2019
Provider time and costs to vaccinate adult patients: Impact of time counseling without vaccinationAngela Shen, Olga Khavjou, Grant King, et al.
Expert Review of Vaccines|May 13, 2025
Modeling the potential public health and economic impact and cost-effectiveness of vaccination strategies using an adapted COVID-19 vaccine in MexicoCarlos Fernando Mendoza, Jose Luis Huerta, Iustina Chirila, et al.
Medical Care|April 26, 2019
Estimating the Costs and Income of Providing Vaccination to Adults and ChildrenBenjamin Yarnoff, David Kim, Fangjun Zhou, et al.
Vaccine|September 10, 2019
Analysis of the profitability of adult vaccination in 13 private provider practices in the United StatesBenjamin Yarnoff, Olga Khavjou, Grant King, et al.
Maternal and Child Health Journal|December 15, 2018
Standardized Cost Estimates for Home Visiting: Pilot Study of the Home Visiting Budget Assistance Tool (HV-BAT)Benjamin Yarnoff, Olga Khavjou, Christina Bradley, et al.
Human Vaccines & Immunotherapeutics|September 29, 2023
Cost-effectiveness analysis of PCV20 to prevent pneumococcal disease in the Canadian pediatric populationDerek Lytle, Ana Gabriela Grajales Beltrán, Johnna Perdrizet, et al.
Preventing Chronic Disease|November 7, 2014
Using simulation to compare established and emerging interventions to reduce cardiovascular disease risk in the United StatesJack Homer, Kristina Wile, Benjamin Yarnoff, et al.
Pageof 4